Invention Grant
US07960403B2 Spirotropane compounds and methods for the modulation of chemokine receptor activity
失效
Spirotropane化合物和调节趋化因子受体活性的方法
- Patent Title: Spirotropane compounds and methods for the modulation of chemokine receptor activity
- Patent Title (中): Spirotropane化合物和调节趋化因子受体活性的方法
-
Application No.: US11792581Application Date: 2005-12-09
-
Publication No.: US07960403B2Publication Date: 2011-06-14
- Inventor: Laval Chan Chun Kong , Christophe Moinet , Marc Courchesne , Louis Vaillancourt , Charles Blais , Monica Bubenik
- Applicant: Laval Chan Chun Kong , Christophe Moinet , Marc Courchesne , Louis Vaillancourt , Charles Blais , Monica Bubenik
- Applicant Address: CA Quebec
- Assignee: Virochem Pharma Inc.
- Current Assignee: Virochem Pharma Inc.
- Current Assignee Address: CA Quebec
- Agency: Millen, White, Zelano & Branigan, P.C.
- International Application: PCT/CA2005/001878 WO 20051209
- International Announcement: WO2006/060919 WO 20060615
- Main IPC: A61K31/438
- IPC: A61K31/438 ; C07D471/20
Abstract:
Compounds according to formula (I): wherein A, R1, R2 and R3 are defined as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
Public/Granted literature
- US20080267906A1 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity Public/Granted day:2008-10-30
Information query
